Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Navinta

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6Navinta, LLC

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    RDD
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    RDD
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2024-09-30

    Navinta

    City : Ewing

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8618

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2024-09-30

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    RDD
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    RDD
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2023-05-04

    Navinta

    City : Ewing

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8618

    District :

    Center :

    Project Area : Bioresearch Monitoring

    District Decision : No Action Indicated

    Inspection End Date : 2023-05-04

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    RDD
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    RDD
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2019-03-28

    Navinta

    City : Ewing

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8618

    District :

    Center :

    Project Area : Bioresearch Monitoring

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2019-03-28

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    RDD
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    RDD
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-08-18

    Navinta

    City : Ewing

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8618

    District :

    Center :

    Project Area : Postmarket Surv. and Epidemiolog...

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-08-18

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    RDD
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    RDD
    Not Confirmed

    District Decision : Official Action Indicated

    Inspection End Date : 2016-05-16

    Navinta

    City : Ewing

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8618

    District :

    Center :

    Project Area : Bioresearch Monitoring

    District Decision : Official Action Indicated

    Inspection End Date : 2016-05-16

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    06

    FDA Audited

    USA
    RDD
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    RDD
    Not Confirmed

    District Decision : No Action Indicated

    Inspection End Date : 2015-08-10

    Navinta

    City : Ewing

    State : New Jersey

    Country/Area : U.S.A

    Zip : 8618

    District :

    Center :

    Project Area : Drug Quality Assurance

    District Decision : No Action Indicated

    Inspection End Date : 2015-08-10

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Contact Navinta and get a quotation

    Navinta is a supplier offers 9 products (APIs, Excipients or Intermediates).

    Find Cisatracurium Besylate bulk with DMF offered by Navinta

    Find Colesevelam Hydrochloride bulk with DMF offered by Navinta

    Find Crizotinib bulk with DMF offered by Navinta

    Find Diazepam bulk with DMF offered by Navinta

    Find Glycerol Phenylbutyrate bulk with DMF offered by Navinta

    Find Sodium Phenylbutyrate bulk with DMF offered by Navinta

    Find Tafamidis Meglumine bulk with DMF offered by Navinta

    Find Triheptanoin bulk with DMF offered by Navinta

    Find Remifentanil bulk offered by Navinta

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.